Green Cross Holdings Corporation (KRX:005257)

South Korea flag South Korea · Delayed Price · Currency is KRW
27,550
-350 (-1.25%)
Last updated: Oct 2, 2025, 9:00 AM KST
-1.25%
Market Cap712.81B
Revenue (ttm)2.27T
Net Income (ttm)117.43B
Shares Outn/a
EPS (ttm)2,586.53
PE Ratio6.07
Forward PEn/a
Dividend500.00 (1.82%)
Ex-Dividend DateDec 27, 2024
Volume1,746
Average Volume1,639
Open28,000
Previous Close27,900
Day's Range27,500 - 28,000
52-Week Range18,300 - 73,900
Beta1.10
RSI47.00
Earnings DateNov 14, 2025

About Green Cross Holdings

Green Cross Holdings Corporation operates as a biotechnology company. The company provides prescription drugs and over the counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and varicella; recombinant treatments for acquired thrombotic thrombocytopenic purpura, fabry, hemophilia, hunterase, colon cancer... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1967
Employees 144
Stock Exchange Korea Stock Exchange
Ticker Symbol 005257
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.